The North America Thalassemia Market is supported by the development of specialized hematology services and advanced treatment programs. Healthcare providers are adopting modern diagnostic, transfusion, and therapeutic approaches to address the needs of patients with thalassemia. Continued investment in specialized care is supporting improvements in disease management across the region. The...